cyclosporine and Cardiovascular Diseases

cyclosporine has been researched along with Cardiovascular Diseases in 117 studies

Research

Studies (117)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	14 (11.97)	18.2507
2000's	63 (53.85)	29.6817
2010's	36 (30.77)	24.3611
2020's	4 (3.42)	2.80

Authors

Authors	Studies
Brodowski, L; Meyer, N; Schröder-Heurich, B; von Kaisenberg, C; von Versen-Höynck, F	1
Cho, JH; Choi, JY; Huh, S; Hwang, I; Jung, HY; Kim, CD; Kim, HK; Kim, YL; Kwon, E; Lim, JH; Park, SH; Won, DI	1
Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Farley Prater, EA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Wong, EB; Wu, JJ	1
Ciałkowska-Rysz, A; Franczyk, B; Gluba-Brzózka, A; Radek, M; Rysz, J	1
Ahn, KJ; Cho, YA; Choe, YB; Hong, JR; Hong, JY; Jeong, H; Kim, H; Kim, SM; Lee, YW; Yang, HS	1
Aguiar, D; Baroja-Mazo, A; Casafont, F; Cuadrado, A; de la Mata, M; Herrero, JI; Martínez-Urbistondo, D; Montero, J; Pons, JA; Puchades, L; Rincón, D; Rodríguez-Perálvarez, M; Rubín, A; Salcedo, M; Serrano, T	1
Brocke, J; Bruckner, T; Giese, T; Meuer, S; Morath, C; Schaier, M; Sommerer, C; Zeier, M	1
Bakker, SJL; Bemelman, FJ; de Fijter, HW; de Vries, APJ; Homan van der Heide, JJ; Said, MY; Sanders, JSF; van Dijk, M; van Roon, AM	1
Dadlez, M; Hryniewiecka, E; Jaźwiec, R; Kosieradzki, M; Nazarewski, S; Pączek, L; Samborowska, E; Żegarska, J; Żochowska, D	1
Bárczi, A; Dégi, AA; Dezsőfi, A; Kis, É; Reusz, GS; Szabó, D	1
Albhaisi, S; Arshad, T; Bhati, C; Driscoll, C; Lee, E; Patel, S; Reichman, T; Siddiqui, MB; Siddiqui, MS; Wolver, S	1
Adamowicz, A; Brzezińska, B; Junik, R; Kamińska, A; Włodarczyk, Z	1
Plischke, M; Riegersperger, M; Seidinger, D; Sengoelge, G; Steiner, S; Sunder-Plassmann, G; Winkelmayer, WC	1
Bagel, J; Blauvelt, A; Hsu, S; Hugh, J; Lebwohl, M; Nijhawan, RI; Van Voorhees, AS; Weinberg, JM	1
Burden, AD; Burfield, L	1
Dirican, M; Ersoy, A; Gullulu, M; Kahvecioglu, S	1
Burke, N; Dongworth, RK; Hall, AR; Hausenloy, DJ	1
Hu, X; Wang, W; Xu, Y; Xue, W; Zhang, Q; Zhang, X	1
Ahlehoff, O; Bryld, LE; Gislason, G; Gniadecki, R; Hansen, PR; Iversen, L; Kristensen, SL; Lasthein, S; Lindhardsen, J; Skov, L; Torp-Pedersen, C	1
Czubkowski, P; Jankowska, I; Pawłowska, J; Socha, P; Wierzbicka, A	1
Kirby, B; Ryan, C	1
Baños, I; Citores, MJ; Cuervas-Mons, V; de la Fuente, S; Duca, A	1
Coss, E; Dierkhising, R; Fan, C; Fussner, LA; Heimbach, JK; Leise, MD; Watt, KD	1
Chagas, C; Lebre, L; Machado, D; Magalhães-Costa, P	1
Augustin, M; Mrowietz, U; Radtke, MA; Reich, K; Rustenbach, SJ; Spehr, C; Thaci, D	1
Boillot, O; Collardeau-Frachon, S; Di Filippo, M; Dumortier, J; Lachaux, A; Peretti, N; Rivet, C; Roblin, E; Sassolas, A; Serusclat, A	1
Camarena-Arias, PA; García-Bello, JA; Mendoza-Gómez, E; Romo-Del Río, EG; Santos-Caballero, M	1
Kronbichler, A; Mayer, G; Neumann, I	1
Cuervas-Mons, V; D'Avola, D; Fábrega, E; Fraga, E; Gómez, MA; Herrero, JI; Jimenez, C; Lladó, L; Lopez, P; Martí, J; Ortiz de Urbina, J; Otero, E; Rios, A; Rodrigo, JM; Serrano, MT; Suarez, F	1
Bartucci, M; Bolin, P; First, MR; Gao, J; Henning, AK; Holman, J; Mulloy, L; Shihab, FS	1
Nagami, GT; Paige, NM	1
Beckebaum, S; Broelsch, CE; Cicinnati, VR; Gerken, G; Klein, CG; Paul, A; Saner, F; Sotiropoulos, GC	1
Bachleda, P; Dedochova, J; Horak, P; Horcicka, V; Krejci, K; Strebl, P; Valkovsky, I; Zadrazil, J; Zahalkova, J	1
Brown, L; Iyer, A	1
Castagneto, M; Citterio, F; De Santis, I; Delreno, F; Favi, E; Gargiulo, A; Rossi, E; Salerno, MP; Spagnoletti, G	1
Bergallo, M; Capuano, M; Costa, C; Esposito, A; Giliberti, A; Iavicoli, G; Lettieri, E; Rossano, R; Sessa, A	1
Beckebaum, S; Cicinnati, VR; Gerken, G; Klein, C; Paul, A; Saner, F; Schmitz, K; Sotiropoulos, GC; Varghese, J	1
Drube, J; Fehrenbach, H; Feneberg, R; Fründ, S; Höcker, B; John, U; Klaus, G; Pohl, M; Tönshoff, B; Weber, LT; Wühl, E; Zimmering, M	1
Seymen, HO; Seymen, P; Titiz, MI; Türkmen, MF; Yildiz, M	1
Block, A; Campistol, J; Di Russo, G; Durrbach, A; Florman, S; Garcia, VD; Garg, P; Grinyó, J; Pearson, T; Pestana, JM; Rial, Mdel C; Vincenti, F; Xing, J	1
Jessup, W; Kockx, M; Kritharides, L	1
Beschmann, H; Boehncke, S; Boehncke, WH; Diehl, S; Fichtlscherer, S; Garbaraviciene, J; Hardt, K; Salgo, R; Thaçi, D	1
Block, A; Bresnahan, B; Campistol, J; Duan, T; Durrbach, A; Glicklich, A; Grinyó, J; Gujrathi, S; Lang, P; Larsen, CP; Mancilla-Urrea, E; Neumayer, HH; Pestana, JM; Vanrenterghem, Y; Vincenti, F	1
Cucchiari, D; Graziani, G; Ponticelli, C	1
Daga, JA; García, DM; Grande, RG; Lombardo, JD; López, JM; Pérez, MJ; Rey, JM; Taybi, BJ	1
Azmi, MT; Hamidon, BB; Kong, CT; Mohd Shahrir, MS; Sazliyana, S; Tan, HJ	1
Busque, S; Cantarovich, M; Gaber, AO; Gaston, R; Huizinga, RB; Ling, S; Mayo, PR; Meier-Kriesche, HU; Mulgaonkar, S	1
Berland, Y; Brunet, P; Burtey, S; Daniel, L; Dussol, B; Indreies, M; Loundou, A; Moal, V; Moussi-Frances, J; Purgus, R; Vacher-Coponat, H	1
Burgos, FJ; Fernandez-Rodriguez, A; Galeano, C; Jiménez, S; Marcén, R; Quereda, C; Teruel, JL	1
Castroagudin, JF; Conde, R; Delgado, M; González-Quintela, A; Mella, C; Otero, E; Padin, E; Segade, FR; Tomé, S; Varo, E	1
Corless, CL; Olyaei, AJ; Rabkin, JM; Rosen, HR	2
Boucher, A; Dandavino, R; Lauzon, L; Masse, M; Morin, M	1
Baan, CC; Balk, AH; Maat, LP; van Riemsdijk, IC; Vantrimpont, PM; Weimar, W	1
Andany, MA; Kasiske, BL	1
Bergeron, J; Després, JP; Houde, I; Lachance, JG; Lemieux, I; Noël, R; Pascot, A; Radeau, T	1
Cesana, B; Montagnino, G; Ponticelli, C; Tarantino, A; Villa, M	1
Budde, K; Fritsche, L; Neumayer, HH	1
Chavers, BM; Gillingham, KJ; Hårdstedt, M	1
Moreno, AJ; Oliveira, PJ; Palmeira, CM; Rolo, AP; Santos, MS; Seiça, R	1
Burke, JT; Campistol, JM; Legendre, C; Squifflet, JP	1
Cosio, FG; Larson, TS	1
Chueh, SC; Kahan, BD	1
Bakker, RC; Bruijn, JA; de Fijter, JW; Hollander, AA; Mallat, MJ; Paul, LC	1
Alvarez, A; Cobo, M; González-Posada, J; Hernández, D; Jiménez, A; Lorenzo, V; Oppenheimer, F; Torregrosa, V; Torres, A	1
Auchincloss, H; Baid-Agrawal, S; Cosimi, AB; Delmonico, FL; Farrell, M; Pascual, M; Shih, V; Tolkoff-Rubin, NE; Williams, WW	1
Artz, MA; Boots, JM; Borm, G; Christiaans, MH; Hilbrands, LB; Ligtenberg, G; Moons, P; Roodnat, JI; Vos, PF	1
Cardarelli, F; Cosimi, AB; Delmonico, FL; Farrell, ML; Pascual, M; Saidman, SL; Shih, V; Tolkoff-Rubin, N; Winkelmayer, WC; Wong, W	1
Fraunberger, P; Groetzner, J; Jung, S; Kaczmarek, I; Landwehr, P; Meiser, BM; Müller, M; Reichart, B; Stempfle, HU; Uberfuhr, P; Weis, M	1
Clavien, PA; Dahm, F; Weber, M	1
Gerhardt, U; Heck, M; Hohage, H; Suwelack, BM; Welling, U; Zeh, M	1
Biesenbach, G; Janko, O; Schmekal, B	1
Jardine, AG	1
Banks, M; Kitas, GD; Raza, K	1
Abdelmalek, MF; Gagliardi, R; Granger, D; Holt, C; Kam, I; Klintmalm, G; Langnas, A; Lucey, MR; Shetty, K; Tzakis, A; Woodle, ES	1
Gerhardt, UW; Heck, M; Hillebrandt, U; Hohage, H; Suwelack, BM; Welling, U; Zeh, M	1
Bourbigot, B; Budde, K; Campbell, S; Eris, J; Krämer, BK; Krüger, B; Neumayer, HH; Pfalzer, B; Pietrzyk, M; Stahl, R; Vitko, S; Whelchel, J	1
Banas, B; Böger, C; Krämer, BK; Krüger, B; Mack, M; Marienhagen, J; Obed, A; Paczek, L; Pietrzyk, M	1
Dominguez-Gil, B; Morales, JM	1
Beck, Y; Kamatani, N; Mushiroda, T; Nakamura, Y; Ohnishi, Y; Saito, S; Tahara, H; Takasaki, J; Tanaka, Y	1
Ferraris, JR; Ghezzi, L; Krmar, RT; Waisman, G	1
Magalhães, ME	1
Edlich, F; Fischer, G	1
Kotyla, PJ; Kucharz, EJ; Lewicki, M; Sliwińska-Kotyla, B	1
Eisen, H	1
Boots, JM; Christiaans, MH; Dackus, J; Gelens, M; van Duijnhoven, EM; van Hooff, JP	1
Badiou, S; Chong, G; Cristol, JP; Dupuy, AM; Garrigue, V; Mourad, G	1
Cardella, CJ; Cattran, DC; Chowdhury, N; Cole, EH; Famure, O; Fenton, SS; Huang, M; Kim, SJ; Nash, MM; Park, J; Prasad, GV; Thenganatt, MA; Zaltzman, JS	1
Alarcón, A; Bravo, J; Chahin, J; Marcén, R	1
Andrés, A; Arias, M; Domínguez, B; Fernández-Fresnedo, G; Fernández-Juárez, G; Marcén, R; Morales, JM; Ortuño, J; Pascual, J; Rodrigo, E	1
Coulon, F; Haspot, F; Martinet, B; Mérieau, E; Renaudin, K; Séveno, C; Vanhove, B	1
Bestard, O; Cruzado, JM; Gil-Vernet, S; Grinyó, JM; Martínez-Castelao, A; Moreso, F; Rama, I; Riera, L; Serón, D; Torras, J	1
Joss, N; Junor, BJ; McMillan, MA; Rodger, RS	1
Gawor, Z; Matych, J; Pierzchalska-Mudyna, T; Piotrowski, G; Rybińska, A; Sikorska-Radek, P; Szuflet, A; Tomaszek, M; Zbróg, Z	1
Checa, MD; Fernández, A; García, JJ; González-Posada, JM; Hernández, D; Hortal, L; Miquel, R; Porrini, E; Rodríguez, A; Rufino, M; Torres, A	1
Beutner, KR; Bhushan, R; Elmets, CA; Feldman, SR; Gordon, KB; Gottlieb, A; Koo, JY; Korman, NJ; Lebwohl, M; Leonardi, CL; Menter, A; Van Voorhees, AS	1
Breckenridge, C; Gault, MH; Harnett, J; Longerich, LL; Purchase, L	1
Dieplinger, H; König, P; Königsrainer, A; Kronenberg, F; Lhotta, K; Margreiter, R	1
Conway, PA; Davis, CP; Madras, PN; Monaco, AP; Sahyoun, AI; Shaffer, D; Simpson, MA	1
Steinhäuslin, F	1
Giles, M; Lipkin, GW; Raine, AE; Tucker, B	1
Buckle, S; Burgess, E; Klassen, J; Paul, LC; Sutherland, F	2
Artamendi Larrañaga, M; Gómez Alamillo, C; Huarte Loza, E; Rodríguez Martín, F; Sánchez Casajús, A; Sierra Carpio, M	1
Bechstein, WO; Guckelberger, O; Jonas, S; Knoop, M; Kratschmer, B; Langrehr, JM; Lemmens, HP; Luesebrink, R; Neuhaus, P; Neuhaus, R	1
Bechstein, WO; Guckelberger, O; Jonas, S; Kratschmer, B; Lemmens, HP; Luesebrink, R; Neuhaus, PL; Neuhaus, R	1
Kasiske, BL	1
Baroni, A; Cusinato, S; Fabiano, M; Pozzato, M; Salomone, M; Serra, A; Vallero, A	1
Bradley, JA; Briggs, JD; Junor, BJ; MacPhee, IA; MacPherson, SG; McMillan, MA; Rodger, RS; Watson, MA	1
Barenbrock, M; Hausberg, M; Kisters, K; Kosch, M; Rahn, KH	1
Oppenheimer, F	1
Burkhardt, K; Hauser, IA; Koch, C; Mayer-Kadner, I; Renders, L; Schärffe, S; Schmieder, RE; Veelken, R	1
Averna, M; Barbagallo, CM; Basili, S; Caputo, F; Cefalù, AB; Davì, G; Ganci, A; Giammarresi, C; Notarbartolo, A; Sparacino, V	1
Buonomo, O; Casciani, CU; Cipriani, S; Danese, V; Mazzarella, V; Pisani, F; Pollicita, S; Rodio, F; Simonetti, G; Splendiani, G	1
First, MR	1
Friedman, A	1

Reviews

15 review(s) available for cyclosporine and Cardiovascular Diseases

Article	Year
Diabetes and Cardiovascular Risk in Renal Transplant Patients. International journal of molecular sciences, 2021, Mar-26, Volume: 22, Issue:7 Topics: Animals; Cardiovascular Diseases; Cyclosporine; Diabetes Mellitus; Heart Disease Risk Factors; Humans; Immunosuppressive Agents; Insulin Resistance; Kidney Failure, Chronic; Kidney Transplantation; Postoperative Complications; Prevalence; Renal Dialysis; Tacrolimus; TOR Serine-Threonine Kinases; Transplant Recipients	2021
From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. Journal of the American Academy of Dermatology, 2014, Volume: 70, Issue:1 Topics: Acitretin; Antibodies, Monoclonal, Humanized; Biological Therapy; Cardiovascular Diseases; Cyclosporine; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Mycophenolic Acid; Psoriasis; PUVA Therapy; Tumor Necrosis Factor-alpha; Ustekinumab	2014
Psoriasis. The journal of the Royal College of Physicians of Edinburgh, 2013, Volume: 43, Issue:4 Topics: Acitretin; Administration, Topical; Cardiovascular Diseases; Cyclosporine; Dermatologic Agents; Humans; Methotrexate; Phototherapy; Psoriasis; Tumor Necrosis Factor-alpha	2013
Targeting mitochondria for cardioprotection: examining the benefit for patients. Future cardiology, 2014, Volume: 10, Issue:2 Topics: Cardiopulmonary Bypass; Cardiotonic Agents; Cardiovascular Diseases; Cell Death; Cyclosporine; Free Radical Scavengers; Humans; Immunosuppressive Agents; Ischemic Postconditioning; Ischemic Preconditioning; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitophagy; Myocytes, Cardiac; Organophosphorus Compounds; Oximes; Percutaneous Coronary Intervention; Reactive Oxygen Species; Secosteroids; Ubiquinone	2014
Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation: a meta-analysis. Chinese medical journal, 2014, Volume: 127, Issue:12 Topics: Calcineurin; Cardiovascular Diseases; Cyclosporine; Humans; Hyperlipidemias; Hypertension; Kidney Transplantation; Metabolic Syndrome; Randomized Controlled Trials as Topic; Tacrolimus	2014
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Dermatologic clinics, 2015, Volume: 33, Issue:1 Topics: Acitretin; Adipokines; Alcoholism; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Comorbidity; Cyclosporine; Dermatologic Agents; Diabetes Mellitus; Fumarates; Humans; Immunosuppressive Agents; Inflammation; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; Risk Factors; Smoking; Tumor Necrosis Factor-alpha; Ustekinumab	2015
Is mycophenolate more than just an immunosuppressant?--An overview. Indian journal of biochemistry & biophysics, 2009, Volume: 46, Issue:1 Topics: Animals; Antioxidants; Blood Vessels; Calcineurin Inhibitors; Cardiovascular Diseases; Cardiovascular System; Cyclosporine; Endothelial Cells; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; NADPH Oxidases; Oxidative Stress; rac1 GTP-Binding Protein; Reactive Oxygen Species; Tacrolimus	2009
Cyclosporin A and atherosclerosis--cellular pathways in atherogenesis. Pharmacology & therapeutics, 2010, Volume: 128, Issue:1 Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Cyclosporine; Humans; Immunosuppressive Agents; NFATC Transcription Factors; Signal Transduction	2010
Hypertension in kidney transplant recipients. Transplant international : official journal of the European Society for Organ Transplantation, 2011, Volume: 24, Issue:6 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcineurin Inhibitors; Calcium Channel Blockers; Cardiovascular Diseases; Cyclosporine; Diuretics; Glucocorticoids; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Life Style; Renal Artery Obstruction; Vascular Resistance	2011
[Treatment of hypercholesterolemia in kidney transplant recipients]. Deutsche medizinische Wochenschrift (1946), 2003, Apr-17, Volume: 128, Issue:16 Topics: Aryl Hydrocarbon Hydroxylases; Cardiovascular Diseases; Cyclosporine; Cytochrome P-450 CYP3A; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunosuppressive Agents; Indoles; Kidney Transplantation; Oxidoreductases, N-Demethylating; Primary Prevention; Risk Factors	2003
Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine. Transplant international : official journal of the European Society for Organ Transplantation, 2005, Volume: 18, Issue:4 Topics: Cardiovascular Diseases; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Risk; Tacrolimus	2005
Cardiovascular risk profile with the new immunosuppressive combinations after renal transplantation. Journal of hypertension, 2005, Volume: 23, Issue:9 Topics: Adrenal Cortex Hormones; Cardiovascular Diseases; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Risk Factors; Sirolimus; Tacrolimus; Transplantation, Homologous	2005
Pharmacological targeting of catalyzed protein folding: the example of peptide bond cis/trans isomerases. Handbook of experimental pharmacology, 2006, Issue:172 Topics: Animals; Cardiovascular Diseases; Catalysis; Cyclophilins; Cyclosporine; Drug Design; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Inflammation; Neoplasms; NIMA-Interacting Peptidylprolyl Isomerase; Peptidylprolyl Isomerase; Protein Folding; Reperfusion Injury; Skin Diseases; Tacrolimus Binding Protein 1A	2006
[Risk of atherosclerosis development in patients with systemic lupus erythematosus]. Polskie Archiwum Medycyny Wewnetrznej, 2005, Volume: 114, Issue:5 Topics: Adrenal Cortex Hormones; Arteriosclerosis; Autoantibodies; Azathioprine; Blood Coagulation Disorders; Cardiovascular Diseases; Causality; Comorbidity; Cyclosporine; Disease Progression; Female; Humans; Lupus Erythematosus, Systemic; Myocardial Infarction; Risk Factors	2005
Preservation of renal function and cardiovascular risk factors. Transplantation proceedings, 2006, Volume: 38, Issue:7 Topics: Cardiovascular Diseases; Cyclosporine; Graft Survival; Hemodynamics; Humans; Immunosuppressive Agents; Kidney Transplantation; Risk Factors; Tacrolimus; Treatment Failure	2006

Trials

28 trial(s) available for cyclosporine and Cardiovascular Diseases

Article	Year
Improved Pulse Wave Velocity and Renal Function in Individualized Calcineurin Inhibitor Treatment by Immunomonitoring: The Randomized Controlled Calcineurin Inhibitor-Sparing Trial. Transplantation, 2018, Volume: 102, Issue:3 Topics: Calcineurin Inhibitors; Cardiovascular Diseases; Cyclosporine; Glomerular Filtration Rate; Humans; Kidney Transplantation; NFATC Transcription Factors; Prospective Studies; Pulse Wave Analysis	2018
Long-term cardiovascular outcome of renal transplant recipients after early conversion to everolimus compared to calcineurin inhibition: results from the randomized controlled MECANO trial. Transplant international : official journal of the European Society for Organ Transplantation, 2018, Volume: 31, Issue:12 Topics: Adult; Basiliximab; Calcineurin; Calcineurin Inhibitors; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cyclosporine; Everolimus; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Male; Middle Aged; Prednisolone; Risk Factors; ROC Curve; Time Factors; TOR Serine-Threonine Kinases; Transplant Recipients; Treatment Outcome	2018
Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients. Transplantation, 2013, Jun-15, Volume: 95, Issue:11 Topics: Adult; Aged; Cardiovascular Diseases; Cell Count; Cyclosporine; Endothelial Cells; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Stem Cells; Tacrolimus; Transplantation	2013
Cardiovascular risk factors after conversion from cyclosporine to tacrolimus in children after liver transplantation. Annals of transplantation, 2014, Nov-20, Volume: 19 Topics: Adolescent; Cardiovascular Diseases; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Living Donors; Male; Prospective Studies; Risk Factors; Tacrolimus; Treatment Outcome	2014
Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results. Transplantation, 2008, Jul-15, Volume: 86, Issue:1 Topics: Adult; Cardiovascular Diseases; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Lipids; Male; Middle Aged; Prospective Studies; Quality of Life; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome; United States	2008
Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:2 Topics: Adolescent; Cardiovascular Diseases; Child; Cyclosporine; Female; Glucocorticoids; Growth; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Prospective Studies; Risk Factors; Time Factors	2010
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010, Volume: 10, Issue:3 Topics: Abatacept; Adult; Calcineurin Inhibitors; Cardiovascular Diseases; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunoconjugates; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Risk	2010
Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies). Transplantation, 2011, May-15, Volume: 91, Issue:9 Topics: Abatacept; Adult; Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunoconjugates; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Risk Factors	2011
The PROMISE study: a phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de novo kidney transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2011, Volume: 11, Issue:12 Topics: Cardiovascular Diseases; Cyclosporine; Diabetes Complications; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Hypertension; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Survival Rate; Tacrolimus	2011
A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation. Transplantation, 2012, Feb-27, Volume: 93, Issue:4 Topics: Adult; Antilymphocyte Serum; Azathioprine; Cardiovascular Diseases; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Risk Assessment; Risk Factors; Steroids; Tacrolimus	2012
Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients. Kidney international, 2002, Volume: 62, Issue:5 Topics: Anti-Inflammatory Agents; Apolipoproteins B; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Insulin; Insulin Resistance; Kidney Failure, Chronic; Kidney Transplantation; Male; Prednisone; Risk Factors	2002
Cardiovascular risk factors of sirolimus compared with cyclosporine: early experience from two randomized trials in renal transplantation. Transplantation proceedings, 2003, Volume: 35, Issue:3 Suppl Topics: Cardiovascular Diseases; Cholesterol; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Risk Factors; Sirolimus; Time Factors; Triglycerides	2003
Cardiovascular disease after transplantation: do we know all of the variables? American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2003, Volume: 3, Issue:8 Topics: Cardiovascular Diseases; Cyclosporine; Humans; Kidney Transplantation; Risk Factors; Tacrolimus	2003
Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy. Kidney international, 2003, Volume: 64, Issue:3 Topics: Adult; Azathioprine; Biopsy; Cardiovascular Diseases; Cause of Death; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Neoplasms; Patient Compliance; Proteinuria; Risk Factors; Survival Analysis; Time Factors; Transplantation, Homologous	2003
Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients. Transplantation, 2004, Apr-27, Volume: 77, Issue:8 Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Cyclosporine; Female; Fibrinogen; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Risk Factors; Tacrolimus	2004
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:6 Topics: Blood Glucose; Blood Pressure; Cardiovascular Diseases; Creatinine; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipids; Prospective Studies; Quality of Life; Risk Factors; Tacrolimus	2004
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction. Clinical transplantation, 2004, Volume: 18, Issue:4 Topics: Adult; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cyclosporine; Female; Graft Survival; Homocysteine; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Period; Prednisolone; Prospective Studies; Risk Assessment; Risk Factors; Uric Acid	2004
Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? Transplantation, 2004, Aug-27, Volume: 78, Issue:4 Topics: Adult; Aged; Cardiovascular Diseases; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Treatment Failure	2004
Conversion from cyclosporine to tacrolimus after renal transplantation improves cardiovascular risk factors. International immunopharmacology, 2005, Volume: 5, Issue:1 Topics: Adult; Cardiovascular Diseases; Cholesterol; Creatinine; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; Risk Factors; Tacrolimus; Uric Acid	2005
Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab. Transplantation proceedings, 2005, Volume: 37, Issue:3 Topics: Antibodies, Monoclonal; Basiliximab; Blood Pressure; Cardiovascular Diseases; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Glomerular Filtration Rate; Gonadal Steroid Hormones; Graft Rejection; Humans; Immunosuppressive Agents; Infections; Kidney Function Tests; Kidney Transplantation; Male; Postoperative Complications; Recombinant Fusion Proteins; Risk Factors; Sirolimus	2005
Cardiovascular risk estimates and risk factors in renal transplant recipients. Transplantation proceedings, 2005, Volume: 37, Issue:4 Topics: Cardiovascular Diseases; Cholesterol; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Postoperative Complications; Risk Factors; Tacrolimus	2005
Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21 Suppl 3 Topics: Azathioprine; Cardiovascular Diseases; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Everolimus; Glucocorticoids; Graft Rejection; Heart Transplantation; Hospital Costs; Humans; Immunocompromised Host; Immunosuppressive Agents; Pennsylvania; Postoperative Complications; Risk Factors; Sirolimus; Tunica Intima; Ultrasonography	2006
Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study. Transplantation proceedings, 2006, Volume: 38, Issue:8 Topics: Adult; Aged; Antihypertensive Agents; Cardiovascular Diseases; Cyclosporine; Emulsions; Female; Glomerular Filtration Rate; Humans; Hypercholesterolemia; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Risk Factors; Tacrolimus	2006
Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data. Transplantation, 2007, Mar-15, Volume: 83, Issue:5 Topics: Adult; Azathioprine; Cardiovascular Diseases; Cause of Death; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Neoplasms; Postoperative Complications; Retrospective Studies; Sepsis; Survival; Survival Analysis; Time Factors	2007
NT-proBNP plasma levels and echocardiographic assessment of cardiac function in patients after renal transplantation. Kardiologia polska, 2007, Volume: 65, Issue:4 Topics: Adult; Cardiovascular Diseases; Cyclosporine; Echocardiography; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Tacrolimus; Time Factors; Ventricular Function, Left	2007
Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression. Transplantation, 2007, Sep-27, Volume: 84, Issue:6 Topics: Adult; Calcineurin Inhibitors; Cardiovascular Diseases; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Proteinuria; Survival Analysis; Tacrolimus	2007
Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation. Transplantation, 1998, Nov-15, Volume: 66, Issue:9 Topics: Acute Disease; Adolescent; Adult; Aged; Azathioprine; Blood Pressure; Cardiovascular Diseases; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Infections; Kidney; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome	1998
Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16, Issue:1 Topics: Adult; Aged; Atorvastatin; Cardiovascular Diseases; Cyclosporine; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyridines; Pyrroles; Safety	2001

Other Studies

74 other study(ies) available for cyclosporine and Cardiovascular Diseases

Article	Year
Cyclosporine A and Tacrolimus Induce Functional Impairment and Inflammatory Reactions in Endothelial Progenitor Cells. International journal of molecular sciences, 2021, Sep-08, Volume: 22, Issue:18 Topics: Cardiovascular Diseases; Cell Movement; Cell Proliferation; Chemotaxis; Cyclosporine; Cytokines; Endothelial Cells; Endothelial Progenitor Cells; Humans; Immunosuppressive Agents; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Neovascularization, Pathologic; NF-kappa B; NF-kappa B p50 Subunit; Sesquiterpenes; Signal Transduction; Stem Cells; Tacrolimus; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1	2021
Impact of Conversion From Cyclosporine to Tacrolimus on Glucose Metabolism and Cardiovascular Risk Profiles in Long-Term Stable Kidney Transplant Recipients. Transplantation proceedings, 2019, Volume: 51, Issue:8 Topics: Adult; Cardiovascular Diseases; Cardiovascular System; Cyclosporine; Female; Glucose; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Risk Factors; Tacrolimus	2019
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:1 Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Biological Products; Calcineurin Inhibitors; Cardiovascular Diseases; Child; Child, Preschool; Coal Tar; Comorbidity; Cyclosporine; Dermatologic Agents; Dyslipidemias; Evidence-Based Medicine; Humans; Infant; Infant, Newborn; Inflammatory Bowel Diseases; Insulin Resistance; Mental Health; Metabolic Syndrome; Methotrexate; Nicotinic Acids; Obesity; Photochemotherapy; Psoriasis; Retinoids	2020
The potential impact of systemic anti-inflammatory therapies in psoriasis on major adverse cardiovascular events: a Korean nationwide cohort study. Scientific reports, 2021, 04-21, Volume: 11, Issue:1 Topics: Acitretin; Adult; Aged; Anti-Inflammatory Agents; Cardiovascular Diseases; Cyclosporine; Female; Humans; Incidence; Male; Methotrexate; Middle Aged; Phototherapy; Proportional Hazards Models; Psoriasis; Republic of Korea; Severity of Illness Index; Young Adult	2021
Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients. Annals of transplantation, 2017, May-02, Volume: 22 Topics: Age Factors; Cardiovascular Diseases; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged; Risk Factors; Tacrolimus; Transplant Recipients	2017
Cyclosporine Metabolites' Metabolic Ratios May Be Markers of Cardiovascular Disease in Kidney Transplant Recipients Treated with Cyclosporine A-Based Immunosuppression Regimens. Cardiovascular toxicology, 2019, Volume: 19, Issue:3 Topics: Adult; Cardiotoxicity; Cardiovascular Diseases; Chromatography, Liquid; Cyclosporine; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Poland; Predictive Value of Tests; Risk Assessment; Risk Factors; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Transplant Recipients; Treatment Outcome	2019
Cardiovascular Risk Assessment in Pediatric Liver Transplant Patients. Journal of pediatric gastroenterology and nutrition, 2019, Volume: 68, Issue:3 Topics: Adolescent; Cardiovascular Diseases; Child; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Risk Assessment; Tacrolimus; Transplant Recipients; Vascular Stiffness	2019
The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients. Transplantation, 2019, Volume: 103, Issue:11 Topics: Adiponectin; Aged; Cardiovascular Diseases; Cyclosporine; Diabetes Complications; Dyslipidemias; End Stage Liver Disease; Female; Humans; Immunosuppression Therapy; Insulin Resistance; Liver Transplantation; Male; Metabolism, Inborn Errors; Middle Aged; Obesity; Proportional Hazards Models; Prospective Studies; Risk Assessment; Tacrolimus; Transplant Recipients; Treatment Outcome	2019
Factors associated with glucose metabolism disorders after kidney transplantation. Endokrynologia Polska, 2013, Volume: 64, Issue:1 Topics: Blood Glucose; Cardiovascular Diseases; Causality; Comorbidity; Cyclosporine; Female; Glucose Metabolism Disorders; Glucose Tolerance Test; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Logistic Models; Male; Middle Aged; Obesity; Overweight; Prediabetic State; Risk Factors; Tacrolimus	2013
Effects of calcineurin inhibitors on paraoxonase and arylesterase activity after a kidney transplant. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2014, Volume: 12, Issue:4 Topics: Adult; Aryldialkylphosphatase; Biomarkers; Calcineurin Inhibitors; Carboxylic Ester Hydrolases; Cardiovascular Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prospective Studies; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome; Young Adult	2014
Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:6 Topics: Adult; Aged; Anti-Inflammatory Agents; Biological Products; Cardiovascular Diseases; Cause of Death; Climatotherapy; Cyclosporine; Denmark; Dermatologic Agents; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Methotrexate; Middle Aged; Myocardial Infarction; Phototherapy; Psoriasis; Registries; Retinoids; Severity of Illness Index; Stroke; Tumor Necrosis Factor-alpha; Ustekinumab	2015
Long-term survivors after pediatric liver transplatation are at increased risk for development of cardiovascular disease events: analysis of 30 cases. Transplantation proceedings, 2014, Volume: 46, Issue:9 Topics: Adult; Calcineurin Inhibitors; Cardiovascular Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Postoperative Complications; Risk Factors; Survivors; Tacrolimus; Young Adult	2014
Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2015, Volume: 21, Issue:7 Topics: Adult; Biomarkers; Body Mass Index; Cardiovascular Diseases; Comorbidity; Cyclosporine; Diabetes Complications; End Stage Liver Disease; Female; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Metabolic Syndrome; Middle Aged; Obesity; Odds Ratio; Prevalence; Proportional Hazards Models; Retrospective Studies; Risk Factors; Tacrolimus	2015
Lack of impact of hepatitis C virus infection on graft survival after kidney transplantation--a Portuguese single-center experience. Transplantation proceedings, 2015, Volume: 47, Issue:4 Topics: Adult; Age Factors; Aged; Azathioprine; Cardiovascular Diseases; Case-Control Studies; Cyclosporine; Female; Graft Rejection; Graft Survival; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Portugal; Proportional Hazards Models; Renal Dialysis; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome	2015
Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest. Archives of dermatological research, 2015, Volume: 307, Issue:10 Topics: Adalimumab; Biological Products; Biological Therapy; Cardiovascular Diseases; Cyclosporine; Dermatologic Agents; Etanercept; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Neoplasms; Psoriasis; Registries; Ustekinumab	2015
Lipid profile and cardiovascular risk factors in pediatric liver transplant recipients. Pediatric transplantation, 2016, Volume: 20, Issue:2 Topics: Adolescent; Apolipoprotein A-I; Apolipoproteins B; Biopsy; Cardiovascular Diseases; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Dyslipidemias; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Liver; Liver Failure; Liver Transplantation; Male; Retrospective Studies; Risk Factors; Tacrolimus; Transplant Recipients; Treatment Outcome	2016
Effect of Immunosuppressive Therapy on Cardiovascular Risk Factor Prevalence in Kidney-Transplanted Children: Comparative Study. Transplantation proceedings, 2016, Volume: 48, Issue:2 Topics: Adolescent; Adult; Cardiovascular Diseases; Child; Cyclosporine; Female; Humans; Hypertension; Hypertriglyceridemia; Hyperuricemia; Immunosuppressive Agents; Immunotherapy; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Prednisone; Prevalence; Retrospective Studies; Risk Factors; Sirolimus; Tacrolimus; Young Adult	2016
Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016, Volume: 31, Issue:10 Topics: Calcineurin Inhibitors; Cardiovascular Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Proteinuria; Risk Factors; Tacrolimus	2016
Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2017, Volume: 23, Issue:4 Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Cyclosporine; Diabetes Mellitus, Type 1; Dyslipidemias; End Stage Liver Disease; Female; Follow-Up Studies; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Liver Transplantation; Male; Metabolic Syndrome; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prevalence; Prospective Studies; Risk Factors; Severity of Illness Index; Spain; Survival Analysis; Tacrolimus; Transplant Recipients	2017
The top 10 things nephrologists wish every primary care physician knew. Mayo Clinic proceedings, 2009, Volume: 84, Issue:2 Topics: Aluminum; Anemia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antacids; Blood Pressure; Blood Urea Nitrogen; Cardiovascular Diseases; Cathartics; Chronic Disease; Contraindications; Creatinine; Cyclosporine; Disease Progression; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Evidence-Based Medicine; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Kidney Diseases; Magnesium; Nephrolithiasis; Nephrology; Phosphates; Primary Health Care; Proteinuria; Recombinant Proteins; Referral and Consultation; Tacrolimus; Urinalysis	2009
Predictive factors of outcome in patients transplanted for hepatitis B. Transplantation, 2009, Mar-27, Volume: 87, Issue:6 Topics: Adult; Aged; Cardiovascular Diseases; Cyclosporine; Female; Graft Survival; Hepatitis B; Humans; Immunoglobulins; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Regression Analysis; Risk Factors; Survival Analysis; Survivors; Tacrolimus; Treatment Outcome; Young Adult	2009
Improvement of cardiovascular risk factors and cosmetic side effects in kidney transplant recipients after conversion to tacrolimus. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2009, Volume: 153, Issue:1 Topics: Adult; Cardiovascular Diseases; Cyclosporine; Female; Gingival Hyperplasia; Humans; Hyperlipidemias; Hypertension; Hypertrichosis; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Risk Factors; Tacrolimus	2009
Cardiovascular risk profile in kidney transplant recipients treated with two immunosuppressive regimens: tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine. Transplantation proceedings, 2009, Volume: 41, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal; Basiliximab; Cardiovascular Diseases; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Recombinant Fusion Proteins; Risk Adjustment; Risk Factors; Sirolimus; Tacrolimus; Transplant Recipients	2009
Immunosuppressive agents and metabolic factors of cardiovascular risk in renal transplant recipients. Transplantation proceedings, 2009, Volume: 41, Issue:4 Topics: Calcineurin Inhibitors; Cardiovascular Diseases; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Glomerular Filtration Rate; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hyperuricemia; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins, HDL; Middle Aged; Risk Factors; Sirolimus; Tacrolimus; Transplant Recipients	2009
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients. Alimentary pharmacology & therapeutics, 2009, Oct-15, Volume: 30, Issue:8 Topics: Adult; Aged; Cardiovascular Diseases; Chronic Disease; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prospective Studies; Risk Factors; Tacrolimus; Treatment Outcome	2009
Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters. Transplantation proceedings, 2009, Volume: 41, Issue:10 Topics: Adult; Body Mass Index; Cardiovascular Diseases; Cyclosporine; Female; Homocysteine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipids; Lipoprotein(a); Lipoproteins, HDL; Male; Patient Selection; Postoperative Complications; Tacrolimus; Treatment Outcome; Triglycerides; Young Adult	2009
Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study. Journal of the European Academy of Dermatology and Venereology : JEADV, 2011, Volume: 25, Issue:10 Topics: Adalimumab; Adipokines; Adult; Aged; Antibodies, Monoclonal, Humanized; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cyclosporine; Etanercept; Female; Fumarates; Humans; Immunoglobulin G; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prospective Studies; Psoriasis; Receptors, Tumor Necrosis Factor; Resistin; Risk Factors; Severity of Illness Index; Treatment Outcome; Vascular Endothelial Growth Factor A	2011
Cardiovascular risk factors after liver transplantation: analysis of related factors. Transplantation proceedings, 2011, Volume: 43, Issue:3 Topics: Cardiovascular Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Multivariate Analysis; Prevalence; Risk Factors; Tacrolimus	2011
Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients. Lupus, 2011, Volume: 20, Issue:12 Topics: Adrenal Cortex Hormones; Adult; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cohort Studies; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Risk Factors; Young Adult	2011
Anemia at 1 year after kidney transplantation has a negative long-term impact on graft and patient outcomes. Transplantation proceedings, 2012, Volume: 44, Issue:9 Topics: Adult; Age Factors; Aged; Anemia; Biomarkers; Cardiovascular Diseases; Creatinine; Cyclosporine; Female; Graft Survival; Hematinics; Hemoglobins; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Risk Factors; Serum Albumin; Serum Albumin, Human; Spain; Time Factors; Treatment Outcome	2012
Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy. Transplantation proceedings, 2002, Volume: 34, Issue:5 Topics: Adolescent; Adult; Aged; Body Weight; Cardiovascular Diseases; Creatinine; Cyclosporine; Diabetes Mellitus; Female; Humans; Hypercholesterolemia; Hypertension; Immunosuppressive Agents; Kidney Function Tests; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prevalence; Retrospective Studies; Risk Factors; Tacrolimus; Transplantation, Homologous	2002
Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients. Transplantation proceedings, 2002, Volume: 34, Issue:5 Topics: Adult; Cardiovascular Diseases; Creatinine; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Graft Rejection; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Incidence; Liver Transplantation; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors	2002
Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients. Transplantation proceedings, 2002, Volume: 34, Issue:5 Topics: Cardiovascular Diseases; Creatinine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Postoperative Complications; Retrospective Studies; Risk Factors; Sex Characteristics; Tacrolimus	2002
Improvement of cardiovascular risk factors in heart transplant recipients after conversion from cyclosporine to tacrolimus: a role of the TGF-beta system. Transplantation proceedings, 2002, Volume: 34, Issue:5 Topics: Adolescent; Adult; Blood Pressure; Cardiovascular Diseases; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Tacrolimus; Transcription, Genetic; Transforming Growth Factor beta; Transplantation, Homologous	2002
Care of the kidney transplant recipient. Vigilant monitoring creates the best outcome. Postgraduate medicine, 2002, Volume: 112, Issue:3 Topics: Cardiovascular Diseases; Cyclosporine; Cytomegalovirus Infections; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Metabolic Diseases; Monitoring, Physiologic; Neoplasms; Risk Assessment; Sirolimus; Tacrolimus; Transplantation, Homologous	2002
Risk factors for late kidney allograft failure. Kidney international, 2002, Volume: 62, Issue:5 Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Cyclosporine; Female; Glomerulonephritis; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Transplantation, Homologous; Treatment Failure	2002
Hyperlipidemia in pediatric kidney transplant recipients treated with cyclosporine. Pediatric nephrology (Berlin, Germany), 2003, Volume: 18, Issue:6 Topics: Adolescent; Cardiovascular Diseases; Child; Child, Preschool; Cyclosporine; Female; Glycosuria, Renal; Humans; Hypercholesterolemia; Hypertriglyceridemia; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Prevalence; Retrospective Studies; Risk Factors	2003
Chronic cholestasis and cardiac mitochondrial function in Wistar rats: a model for cardiovascular alterations in chronic liver disease? Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2003, Volume: 22, Issue:1 Topics: 1-Naphthylisothiocyanate; Animals; Calcium; Cardiovascular Diseases; Cholestasis; Chronic Disease; Cyclosporine; Disease Models, Animal; Female; Fibrosis; Liver Diseases; Mitochondria, Heart; Oxidative Stress; Rats; Rats, Wistar	2003
Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis. Transplantation, 2003, Jul-27, Volume: 76, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Cardiovascular Diseases; Cohort Studies; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Prednisolone; Prognosis; Retrospective Studies; Risk Factors; Severity of Illness Index; Sirolimus	2003
Cardiovascular risk profile in nondiabetic renal transplant patients: cyclosporine versus tacrolimus. Transplantation proceedings, 2003, Volume: 35, Issue:5 Topics: Adult; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cyclosporine; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Renal Replacement Therapy; Risk Factors; Tacrolimus	2003
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:12 Topics: Cardiovascular Diseases; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Quality of Life; Risk Factors; Tacrolimus	2004
Impact of kidney transplantation on glycemic control and cardiovascular risk factors in insulin-treated diabetic patients receiving cyclosporine: a longitudinal study. Transplantation proceedings, 2004, Volume: 36, Issue:10 Topics: Adult; Cardiovascular Diseases; Cyclosporine; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Insulin; Kidney Transplantation; Lipids; Longitudinal Studies; Male; Middle Aged; Risk Factors; Time Factors	2004
Reversing myocardial microvascular disease in a patient with rheumatoid arthritis. The Journal of rheumatology, 2005, Volume: 32, Issue:4 Topics: Arthritis, Rheumatoid; Cardiovascular Diseases; Coronary Angiography; Coronary Circulation; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Microcirculation; Middle Aged; Prednisolone; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon	2005
A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:5 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Blood Pressure; Cardiovascular Diseases; Cardiovascular System; Child; Child, Preschool; Cholesterol; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Ischemia; Kidney; Lipid Metabolism; Liver Diseases; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome; Triglycerides	2005
Cyclosporine and tacrolimus: influence on cardiovascular risk factors. Transplantation proceedings, 2005, Volume: 37, Issue:2 Topics: Adult; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cyclosporine; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipids; Postoperative Complications; Retrospective Studies; Risk Assessment; Tacrolimus	2005
A model of prediction system for adverse cardiovascular reactions by calcineurin inhibitors among patients with renal transplants using gene-based single-nucleotide polymorphisms. Journal of human genetics, 2005, Volume: 50, Issue:9 Topics: Calcineurin Inhibitors; Cardiovascular Diseases; Case-Control Studies; Cyclosporine; Genetic Predisposition to Disease; Genetic Variation; Humans; Kidney Transplantation; Pharmacogenetics; Polymorphism, Single Nucleotide; Prognosis; Risk Factors; Tacrolimus	2005
Potential cardiovascular risk factors in paediatric renal transplant recipients. Pediatric nephrology (Berlin, Germany), 2006, Volume: 21, Issue:1 Topics: Adolescent; Adult; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Child; Child, Preschool; Cholesterol; Cyclosporine; Fasting; Female; Humans; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Retrospective Studies; Tacrolimus; Time Factors	2006
[Mechanisms of rhabdomyolysis with statins]. Arquivos brasileiros de cardiologia, 2005, Volume: 85 Suppl 5 Topics: Apoptosis; Cardiovascular Diseases; Creatine Kinase; Cyclosporine; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rhabdomyolysis	2005
Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications? Transplantation proceedings, 2006, Volume: 38, Issue:7 Topics: Adult; Apolipoprotein C-III; Apolipoproteins B; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins, LDL; Male; Middle Aged; Postoperative Complications; Tacrolimus; Triglycerides	2006
A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients. Transplantation, 2006, Oct-15, Volume: 82, Issue:7 Topics: Adolescent; Adult; Cardiovascular Diseases; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Male; Patient Selection; Postoperative Complications; Risk Factors; Tacrolimus	2006
Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain. Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:12 Suppl 3 Topics: Adult; Cardiovascular Diseases; Cohort Studies; Cyclosporine; Female; Graft Rejection; Humans; Hypercholesterolemia; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Prevalence; Retrospective Studies; Risk Factors; Smoking; Spain	2006
Induction of regulatory cells and control of cellular but not vascular rejection by costimulation blockade in hamster-to-rat heart xenotransplantation. Xenotransplantation, 2007, Volume: 14, Issue:1 Topics: Abatacept; Adenoviridae; Animals; B7-1 Antigen; Cardiovascular Diseases; CD28 Antigens; Cells, Cultured; Cricetinae; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunoconjugates; Male; Rats; Spleen; T-Lymphocytes, Regulatory; Transplantation, Heterologous	2007
Immunosuppression for dual kidney transplantation with marginal organs: the old is better yet. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2007, Volume: 7, Issue:3 Topics: Calcineurin Inhibitors; Cardiovascular Diseases; Cyclosporine; Delayed Graft Function; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone; Risk; Treatment Outcome	2007
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:5 Topics: Acitretin; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Cardiovascular Diseases; Cyclosporine; Depression; Etanercept; Humans; Immunoglobulin G; Interleukin-12; Interleukin-23; Lymphoma; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Smoking; Tumor Necrosis Factor-alpha	2008
Comparison of Lp(a) concentrations and some potential effects in hemodialysis, CAPD, transplantation, and control groups, and review of the literature. Nephron, 1995, Volume: 70, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoprotein B-100; Apolipoproteins A; Apolipoproteins B; Cardiovascular Diseases; Child; Cholesterol; Cyclosporine; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Enzyme-Linked Immunosorbent Assay; Female; Gemfibrozil; Graft Occlusion, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent; Isoenzymes; Kidney; Kidney Function Tests; Kidney Transplantation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Myocardial Ischemia; Peritoneal Dialysis, Continuous Ambulatory; Radioimmunoassay; Reference Values; Renal Dialysis; Triglycerides; Ultrasonography	1995
Conversion from cyclosporin to azathioprine after kidney transplantation. Lancet (London, England), 1995, Jun-10, Volume: 345, Issue:8963 Topics: Apolipoproteins A; Azathioprine; Cardiovascular Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Kidney Transplantation; Phenotype; Prednisone; Thromboembolism	1995
Kidney transplantation in diabetic patients using cyclosporine. Five-year follow-up. Archives of surgery (Chicago, Ill. : 1960), 1995, Volume: 130, Issue:3 Topics: Actuarial Analysis; Boston; Cardiovascular Diseases; Cause of Death; Creatinine; Cyclosporine; Diabetes Mellitus; Diabetic Nephropathies; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Pancreas Transplantation; Retrospective Studies; Survival Rate; Tissue Donors; Treatment Outcome	1995
[After care following kidney transplantation]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1994, May-31, Volume: 83, Issue:22 Topics: Adrenal Cortex Hormones; Azathioprine; Cardiovascular Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infections; Kidney Neoplasms; Kidney Transplantation; Postoperative Care; Postoperative Complications	1994
Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients. Journal of hypertension, 1993, Volume: 11, Issue:4 Topics: Blood Pressure; Blood Pressure Monitors; Cardiovascular Diseases; Cyclosporine; Female; Heart Ventricles; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Myocardium	1993
Post-transplant conversion from cyclosporin to azathioprine: effect on cardiovascular risk profile. Transplant international : official journal of the European Society for Organ Transplantation, 1993, Volume: 6, Issue:3 Topics: Adult; Azathioprine; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cyclosporine; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Risk Factors	1993
[The cardiovascular risk in kidney transplantation. The importance of cyclosporin A]. Revista clinica espanola, 1995, Volume: 195, Issue:12 Topics: Cardiovascular Diseases; Cyclosporine; Humans; Kidney Transplantation; Lipids; Renal Dialysis; Risk Factors	1995
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation? Transplantation proceedings, 1996, Volume: 28, Issue:6 Topics: Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Cyclosporine; Follow-Up Studies; Humans; Hyperglycemia; Hypertension; Hypertriglyceridemia; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Obesity; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Tacrolimus	1996
Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation. Clinical transplantation, 1997, Volume: 11, Issue:1 Topics: Adolescent; Adult; Aged; Blood Glucose; Cardiovascular Diseases; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Obesity; Prednisolone; Retrospective Studies; Risk Factors; Tacrolimus	1997
Cyclosporine and lipid peroxidation. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998, Volume: 31, Issue:1 Topics: Azathioprine; Cardiovascular Diseases; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipid Peroxidation; Lipoproteins, LDL; Oxidation-Reduction; Risk Factors	1998
[Critical review of renal transplantation data from the Piedmontese Regional Dialysis and Transplantation Registry]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1998, Volume: 50, Issue:1 Topics: Adolescent; Adult; Cardiovascular Diseases; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Utilization; Female; Humans; Immunosuppressive Agents; Infant; Infections; Italy; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Neoplasms; Registries; Reoperation; Survival Analysis	1998
Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients. Kidney international, 1999, Volume: 55, Issue:3 Topics: Adult; Biomechanical Phenomena; Blood Flow Velocity; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Case-Control Studies; Cyclosporine; Endothelium, Vascular; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Ultrasonography; Vasodilation	1999
Steroid withdrawal in renal transplant recipients. Transplantation proceedings, 2000, Volume: 32, Issue:1A Suppl Topics: Adult; Cardiovascular Diseases; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Reoperation; Retrospective Studies; Risk Factors; Sirolimus; Steroids; Tacrolimus	2000
Determinants of enhanced thromboxane biosynthesis in renal transplantation. Kidney international, 2001, Volume: 59, Issue:4 Topics: Adult; Antithrombin III; Cardiovascular Diseases; Cholesterol; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Peptide Hydrolases; Postoperative Period; Reference Values; Renal Dialysis; Thromboxanes; von Willebrand Factor	2001
Echographic valuation of risk factors for cardiovascular disease in patients with renal transplantation. Transplantation proceedings, 2001, Volume: 33, Issue:3 Topics: Adult; Cardiovascular Diseases; Carotid Arteries; Creatinine; Cyclosporine; Female; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Regression Analysis; Risk Factors; Ultrasonography	2001
Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population. Transplantation, 2001, Sep-27, Volume: 72, Issue:6 Suppl Topics: Cardiovascular Diseases; Child; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Ohio; Postoperative Complications; Risk Factors; Tacrolimus	2001
Immunosuppression impact on long-term cardiovascular complications after liver transplantation. American journal of surgery, 2002, Volume: 183, Issue:5 Topics: Cardiovascular Diseases; Cyclosporine; Female; Humans; Hypertension; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Tacrolimus; Time Factors	2002
Strategies to improve outcomes after renal transplantation. The New England journal of medicine, 2002, Jun-27, Volume: 346, Issue:26 Topics: Cardiovascular Diseases; Cyclosporine; Homocysteine; Humans; Immunosuppressive Agents; Kidney Transplantation; Risk Factors; Transplantation Tolerance	2002
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.8. Cardiovascular risks. Immunosuppressive therapy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17 Suppl 4 Topics: Adrenal Cortex Hormones; Cardiovascular Diseases; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation	2002
Cardiovascular risk impact of cyclosporine immunosuppression in renal transplant recipients. Transplantation proceedings, 1992, Volume: 24, Issue:6 Topics: Adult; Antihypertensive Agents; Azathioprine; Blood Pressure; Cardiovascular Diseases; Cause of Death; Cholesterol; Cyclosporine; Female; Graft Rejection; Histocompatibility Testing; Humans; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Postoperative Complications	1992